A look back on a year of promise and opportunity
A look back on a year of promise and opportunity

In the search of a cure...

We can see progress. More neuroendocrine tumor (NET) treatment options are emerging. This year, we saw results from scientific research in the clinica new modality of treatment became routinely available in America—peptide receptor radionuclide therapy (PRRT). Other advancements continue down the pipeline bringing us closer to increasing therapeutic options in NET care. (MORE)

Leveraging the latest advancements

In 2018, FDA approved PRRT using Lutetium 177 dotatate to treat gastrointestinal and pancreatic NETs. NETRF is already pursuing advancements in the laboratory to increase PRRT's effectiveness and working to increase the number of people who may benefit from it. (MORE)

Accelerating our understanding of NETs

Your gifts enable us to fund the most promising research on innovative treatment options for neuroendocrine cancers. 

Recruiting the best scientists in the search for a cure

NETRF seeks out world-class researchers around the globe. Four of our NETRF-funded researchers and a 2018 member of our Board of Scientific Advisors were named in the top 1% of their fields worldwide for 2018. (MORE)
In 2018, NETRF announced the largest fundraising campaign in its history—the $10 million Spark Hope campaign. Each and every gift up to $5 million will be matched, allowing donors to magnify the impact of their gift. See why Brendan and Deb Foley got involved with the campaign. (MORE) 
Support NET Research

Meeting more people in more communities 

Through hosting and co-sponsoring regional NET conferences for patients and caregivers, we are reaching more and more people where they live to offer information and insights about NET testing and treatments. 
Woman puts pin on map for her hometown

Offering information online

Where and when you need it

The internet is the main source of health information for many. Yet reliable, accurate information on NETs is still hard to find. NETRF offers comprehensive information and resources for those facing a NET diagnosis. 
attendees at a patient conference

2018: the year in pictures

What to expect in 2019

We expect continued growth and success this year. Already we have many exciting projects underway. Look for announcements this winter about: 
  • 7 new research grants
  • 4 new researchers
  • 3 new study locations
  • Improved and expanded patient education resources

Thank you!

Thank you for your support, participation, and involvement in NETRF's work towards accelerating the search for cures, improving the quality of life for patients, and increasing awareness of neuroendocrine cancer. 
Doctor Database   Patient Groups
Newly Diagnosed   About NETs
DONATE
Facebook Twitter
Contact Us

NET Research Foundation
321 Columbus Avenue, Suite 5R
Boston, MA 02116

(617) 946-1780 | info@netrf.org
The mission of the Neuroendocrine Tumor Research Foundation is to fund research to discover cures and more effective treatments for carcinoid, pancreatic, and related neuroendocrine cancers.

NETRF is a 501(c)(3) organization. All contributions are tax-deductible to the extent allowed by law. To learn more,
view our Audited Financial Statements and IRS Form 990.
powered by emma
Subscribe to our email list.